| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.041 | 0.8 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.036 | 0.8 |